DE69928687D1 - Thermostabile luciferase aus photuris pennsylvanica und pyrophorus plagiophthalamus und hertsellungsmethoden - Google Patents

Thermostabile luciferase aus photuris pennsylvanica und pyrophorus plagiophthalamus und hertsellungsmethoden

Info

Publication number
DE69928687D1
DE69928687D1 DE69928687T DE69928687T DE69928687D1 DE 69928687 D1 DE69928687 D1 DE 69928687D1 DE 69928687 T DE69928687 T DE 69928687T DE 69928687 T DE69928687 T DE 69928687T DE 69928687 D1 DE69928687 D1 DE 69928687D1
Authority
DE
Germany
Prior art keywords
und
luciferase
hertsellungsmethoden
thermostabile
aus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69928687T
Other languages
English (en)
Other versions
DE69928687T2 (de
Inventor
V Wood
P Hall
Monika Gruber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Promega Corp
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Publication of DE69928687D1 publication Critical patent/DE69928687D1/de
Application granted granted Critical
Publication of DE69928687T2 publication Critical patent/DE69928687T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/84—Manufacture, treatment, or detection of nanostructure
    • Y10S977/895—Manufacture, treatment, or detection of nanostructure having step or means utilizing chemical property
    • Y10S977/896—Chemical synthesis, e.g. chemical bonding or breaking
    • Y10S977/898—Enzymatic
DE69928687T 1999-09-15 1999-12-22 Thermostabile luciferase aus photuris pennsylvanica und pyrophorus plagiophthalamus und hertsellungsmethoden Expired - Lifetime DE69928687T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/396,154 US6602677B1 (en) 1997-09-19 1999-09-15 Thermostable luciferases and methods of production
US396154 1999-09-15
PCT/US1999/030925 WO2001020002A1 (en) 1999-09-15 1999-12-22 Thermostable luciferases from photuris pennsylvanica and pyrophorus plagiophthalamus and methods of production

Publications (2)

Publication Number Publication Date
DE69928687D1 true DE69928687D1 (en) 2006-01-05
DE69928687T2 DE69928687T2 (de) 2006-08-24

Family

ID=23566077

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69928687T Expired - Lifetime DE69928687T2 (de) 1999-09-15 1999-12-22 Thermostabile luciferase aus photuris pennsylvanica und pyrophorus plagiophthalamus und hertsellungsmethoden

Country Status (9)

Country Link
US (6) US6602677B1 (de)
EP (2) EP1630231A3 (de)
JP (1) JP4520084B2 (de)
AT (1) ATE311461T1 (de)
AU (1) AU785294B2 (de)
CA (1) CA2350823A1 (de)
DE (1) DE69928687T2 (de)
ES (1) ES2253929T3 (de)
WO (1) WO2001020002A1 (de)

Families Citing this family (188)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602677B1 (en) * 1997-09-19 2003-08-05 Promega Corporation Thermostable luciferases and methods of production
GB9823468D0 (en) 1998-10-28 1998-12-23 Secr Defence Novel enzyme
AU772485C (en) * 1999-10-26 2004-11-18 Promega Corporation Novel enzyme
GB9925161D0 (en) * 1999-10-26 1999-12-22 Secr Defence Novel enzyme
US7879540B1 (en) * 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
US20030157643A1 (en) * 2000-08-24 2003-08-21 Almond Brian D Synthetic nucleic acids from aquatic species
US7083911B2 (en) 2001-02-16 2006-08-01 Promega Corporation Method for detection of ATP
GB0111275D0 (en) 2001-05-09 2001-06-27 Secr Defence Analytical method and kit
US20050276812A1 (en) 2004-06-01 2005-12-15 Genentech, Inc. Antibody-drug conjugates and methods
WO2004027378A2 (en) 2002-09-20 2004-04-01 Promega Corporation Luminescence-based methods and probes for measuring cytochrome p450 activity
EP2325329B1 (de) 2002-12-23 2014-02-12 Promega Corporation Verbesserte Luciferase-Assays
DE10315640A1 (de) * 2003-04-04 2004-10-14 Ignatov, Konstantin Verfahren zur kontrollierten Freisetzung von Komponenten in eine Lösung
WO2005035719A2 (en) * 2003-10-03 2005-04-21 Board Of Control Of Michigan Technological University Modified luciferase
EP1673459B1 (de) 2003-10-10 2012-06-27 Promega Corporation Luciferase biosensor
BR122018071968B8 (pt) 2003-11-06 2021-07-27 Seattle Genetics Inc conjugado de anticorpo-droga, composição farmacêutica, artigo de manufatura e uso de um conjugado de anticorpo-droga
ATE429507T1 (de) * 2004-07-02 2009-05-15 Promega Corp Zusammensetzungen und verfahren zur extraktion und detektion von mikrobiellem atp
US7728118B2 (en) * 2004-09-17 2010-06-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
NZ580115A (en) 2004-09-23 2010-10-29 Genentech Inc Cysteine engineered antibody light chains and conjugates
EP3505191A1 (de) 2004-11-12 2019-07-03 Seattle Genetics, Inc. Auristatine mit einer aminobenzoesäureeinheit am n-ende
EP2778234B1 (de) 2005-05-31 2017-09-27 Promega Corporation Luminogene und fluorogene verbindungen und verfahren für den nachweis von molekülen oder leiden
EP1935986B1 (de) 2005-05-31 2014-04-16 Promega Corporation Luminogene und fluorogene Verbindungen und Verfahren für den Nachweis von Molekülen oder Leiden
GB0513535D0 (en) * 2005-07-01 2005-08-10 Iseao Technologies Ltd Improved methods of detecting microbes
EP2722051B1 (de) 2005-07-07 2018-11-07 Seattle Genetics, Inc. Monomethylvalinverbindungen mit Phenylalaninseitenkettenmodifikationen am C-Terminus
GB0516455D0 (en) * 2005-08-10 2005-09-14 Lumora Ltd pH tolerant luciferase
GB0517005D0 (en) 2005-08-19 2005-09-28 Enigma Diagnostics Ltd Analytical method and kit
EP2327768B1 (de) * 2006-04-03 2015-09-09 Promega Corporation Permutierte und nichtpermutierte Luciferase-Biosensoren
WO2007140371A2 (en) 2006-05-30 2007-12-06 Genentech, Inc. Antibodies and immunoconjugates and uses therefor
CA2662236A1 (en) 2006-09-12 2008-03-20 Genentech, Inc. Methods and compositions for the diagnosis and treatment of cancer
EP2061814B1 (de) 2006-10-27 2012-06-06 Genentech, Inc. Antikörper und immunkonjugate sowie ihre verwendungen
KR101460816B1 (ko) 2006-12-07 2014-11-12 에프. 호프만-라 로슈 아게 포스포이노시타이드 3-키나제 억제제 화합물 및 그의 사용 방법
PE20140614A1 (es) 2007-07-16 2014-05-28 Genentech Inc Anticuerpos anti-cd79b e inmunoconjugados
CA2692819A1 (en) 2007-07-16 2009-01-22 Genentech, Inc. Humanized anti-cd79b antibodies and immunoconjugates and methods of use
ES2399774T3 (es) 2007-09-24 2013-04-03 Genentech, Inc. Compuestos de tiazolopirimidina inhibidores de PI3K y métodos de uso
SI2247620T1 (sl) 2008-01-31 2016-09-30 Genentech, Inc. Protitelesa proti CD79b in imunokonjugati in postopki za uporabo
EP3692988A3 (de) 2008-03-18 2020-10-14 Genentech, Inc. Kombinationen eines anti-her2-antikörper-wirkstoff-konjugats und 5-fu,anti-vegf antikörper, carboplatin oder abt869 sowie verfahren zur verwendung
EP2842575B1 (de) 2008-03-18 2017-09-27 Seattle Genetics, Inc. Auristatin mit einem Heilmittel bindenden Konjugat
US20090286299A1 (en) * 2008-05-15 2009-11-19 Mostafa Ronaghi Engineered luciferases
JP6110591B2 (ja) 2008-05-19 2017-04-05 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ ｃＡＭＰのためのルシフェラーゼバイオセンサー
US7852663B2 (en) 2008-05-23 2010-12-14 Seagate Technology Llc Nonvolatile programmable logic gates and adders
JP2010004758A (ja) * 2008-06-24 2010-01-14 Probex Inc ｃｙｃｌｉｃＧＭＰ検出方法
JP6067222B2 (ja) 2008-07-15 2017-01-25 ジェネンテック， インコーポレイテッド アントラサイクリン誘導体コンジュゲート、その調製方法及び抗腫瘍化合物としてのその用途
CN103983634A (zh) 2008-07-22 2014-08-13 普罗美加公司 基于adp检测的发光磷酸转移酶或atp水解酶测定
WO2010021686A1 (en) 2008-08-18 2010-02-25 Promega Corporation Luminogenic compounds and methods to detect cytochrome p450 3a enzymes
US7985994B2 (en) 2008-09-29 2011-07-26 Seagate Technology Llc Flux-closed STRAM with electronically reflective insulative spacer
US8089132B2 (en) 2008-10-09 2012-01-03 Seagate Technology Llc Magnetic memory with phonon glass electron crystal material
US8045366B2 (en) 2008-11-05 2011-10-25 Seagate Technology Llc STRAM with composite free magnetic element
US8289756B2 (en) 2008-11-25 2012-10-16 Seagate Technology Llc Non volatile memory including stabilizing structures
US7826259B2 (en) 2009-01-29 2010-11-02 Seagate Technology Llc Staggered STRAM cell
UA103918C2 (en) 2009-03-02 2013-12-10 Айерем Элелси N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
JP5709766B2 (ja) 2009-03-12 2015-04-30 ジェネンテック， インコーポレイテッド 造血器腫瘍の治療のためのホスホイノシチド３キナーゼ阻害剤化合物と化学療法剤の併用
CN102471380B (zh) 2009-04-01 2015-01-14 霍夫曼-拉罗奇有限公司 抗FcRH5抗体和免疫偶联物及使用方法
JP2012531212A (ja) 2009-07-03 2012-12-10 アビペップ ピーティーワイ リミテッド イムノコンジュゲート及びその作製方法
US8102703B2 (en) * 2009-07-14 2012-01-24 Crocus Technology Magnetic element with a fast spin transfer torque writing procedure
CN102625807B (zh) 2009-09-08 2016-03-09 霍夫曼-拉罗奇有限公司 4-取代的吡啶-3-基-甲酰胺化合物和使用方法
KR101428346B1 (ko) 2009-09-28 2014-08-07 에프. 호프만-라 로슈 아게 벤즈옥사제핀 ｐｉ3ｋ 억제 화합물 및 사용 방법
JP5546636B2 (ja) 2009-09-28 2014-07-09 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト ベンゾキセピンｐｉ３ｋ阻害剤化合物及び使用方法
CA2781682A1 (en) 2009-12-04 2011-06-09 Genentech, Inc. Multispecific antibodies, antibody analogs, compositions, and methods
SG181814A1 (en) 2009-12-23 2012-07-30 Avipep Pty Ltd Immuno-conjugates and methods for producing them 2
US9556249B2 (en) 2010-02-18 2017-01-31 Genentech, Inc. Neuregulin antagonists and use thereof in treating cancer
PE20130342A1 (es) 2010-04-15 2013-04-20 Spirogen Sarl Pirrolobenzodiacepinas y conjugados de las mismas
WO2011143339A1 (en) 2010-05-11 2011-11-17 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
US9290794B2 (en) 2010-05-11 2016-03-22 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
KR20130098165A (ko) 2010-06-03 2013-09-04 제넨테크, 인크. 항체 및 면역접합체의 이뮤노-ｐｅｔ 영상화 및 그의 용도
CN114246952A (zh) 2010-06-08 2022-03-29 基因泰克公司 半胱氨酸改造的抗体和偶联物
MX336001B (es) 2010-06-18 2016-01-07 Genentech Inc Anticuerpos anti-axl y metodos de uso.
UY33469A (es) 2010-06-29 2012-01-31 Irm Llc Y Novartis Ag Composiciones y metodos para modular la via de señalizacion de wnt
SG10202103336SA (en) 2010-11-02 2021-04-29 Promega Corp Novel coelenterazine substrates and methods of use
WO2012061477A1 (en) 2010-11-02 2012-05-10 Promega Corporation Coelenterazine derivatives and methods of using same
JP5889912B2 (ja) 2010-11-17 2016-03-22 ジェネンテック， インコーポレイテッド アラニニルメイタンシノール抗体コンジュゲート
NZ609448A (en) 2010-12-16 2015-07-31 Hoffmann La Roche Tricyclic pi3k inhibitor compounds and methods of use
CN107098972A (zh) 2010-12-20 2017-08-29 霍夫曼-拉罗奇有限公司 抗间皮素抗体和免疫偶联物
WO2012135440A1 (en) 2011-03-30 2012-10-04 Arizona Board Of Regents, For And On Behalf Of, Arizona State University Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof
CN103874689B (zh) 2011-04-01 2016-04-27 基因泰克公司 Akt抑制剂化合物和威罗菲尼的组合及使用方法
CN103841976A (zh) 2011-04-01 2014-06-04 基因泰克公司 Akt和mek抑制剂化合物的组合及其使用方法
MX342240B (es) 2011-04-07 2016-09-21 Genentech Inc Anticuerpos anti-fgfr4 y metodos de uso.
EP2524918A1 (de) 2011-05-19 2012-11-21 Centro Nacional de Investigaciones Oncológicas (CNIO) Imidazopyrazinderivate als Kinase Inhibitoren
RU2598840C2 (ru) 2011-05-19 2016-09-27 Фундасион Сентро Насиональ Де Инвестигасионес Онколохикас Карлос Iii Новые соединения
KR20140057326A (ko) 2011-08-17 2014-05-12 제넨테크, 인크. 뉴레귤린 항체 및 그의 용도
PT2750713E (pt) 2011-10-14 2016-01-20 Genentech Inc Pirrolobenzodiazepinas e conjugados das mesmas
BR112014010439A2 (pt) 2011-11-03 2017-04-18 F Hoffmann - La Roche Ag compostos, composição farmacêutica, processo de produção, método de tratamento de uma doença ou distúrbio, métodos, kit e uso de uma composição farmacêutica
WO2013067264A1 (en) 2011-11-03 2013-05-10 Genentech, Inc. 8-fluorophthalazin-1 (2h) - one compounds as inhibitors of btk activity
ES2552514T3 (es) 2011-11-03 2015-11-30 Hoffmann-La Roche Ag Compuestos bicíclicos de piperazina
UA111756C2 (uk) 2011-11-03 2016-06-10 Ф. Хоффманн-Ля Рош Аг Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
JP5969620B2 (ja) 2011-11-08 2016-08-17 ザ プロクター アンド ギャンブル カンパニー プレバイオティクスの識別方法及びそれを含む組成物
EP3467119B1 (de) * 2011-11-11 2022-02-23 Promega Corporation Mutante prothease-biosensoren mit verbesserten erkennungseigenschaften
CA2856873A1 (en) 2011-11-23 2013-05-30 Igenica, Inc. Anti-cd98 antibodies and methods of use thereof
AR090549A1 (es) 2012-03-30 2014-11-19 Genentech Inc Anticuerpos anti-lgr5 e inmunoconjugados
MX2014012889A (es) 2012-05-01 2014-11-14 Genentech Inc Anticuerpos e inmunoconjugados anti-pmel17.
JO3300B1 (ar) 2012-06-06 2018-09-16 Novartis Ag مركبات وتركيبات لتعديل نشاط egfr
WO2013184766A1 (en) 2012-06-06 2013-12-12 Irm Llc Compounds and compositions for modulating egfr activity
BR112014028376A2 (pt) 2012-06-08 2018-04-24 Hoffmann La Roche métodos para o tratamento de um distúrbio hiperproliferativo, para a determinação dos compostos, para monitorar, para optimizar a eficácia terapêutica e de identificação de um biomarcador; formulação farmacêutica; utilização de uma combinação terapêutica e de gdc-0032, artigo de manufatura, produto e invenção
BR112015000441A2 (pt) 2012-07-09 2017-12-19 Genentech Inc imunoconjugados, formulação farmacêutica e método de tratamento e método para inbir a proliferação de uma célula positiva para cd22
SG11201500096YA (en) 2012-07-09 2015-02-27 Genentech Inc Immunoconjugates comprising anti - cd79b antibodies
IN2014DN10652A (de) 2012-07-09 2015-09-11 Genentech Inc
AR091701A1 (es) 2012-07-09 2015-02-25 Genentech Inc Anticuerpos anti-cd22 e inmunoconjugados
WO2014033196A1 (en) 2012-08-30 2014-03-06 F. Hoffmann-La Roche Ag Dioxino- and oxazin-[2,3-d]pyrimidine pi3k inhibitor compounds and methods of use
WO2014059028A1 (en) 2012-10-09 2014-04-17 Igenica, Inc. Anti-c16orf54 antibodies and methods of use thereof
JP6270859B2 (ja) 2012-10-12 2018-01-31 エイディーシー・セラピューティクス・エス・アー・エール・エルＡｄｃ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓａｒｌ ピロロベンゾジアゼピン−抗体結合体
KR101995621B1 (ko) 2012-10-12 2019-07-03 에이디씨 테라퓨틱스 에스에이 피롤로벤조디아제핀-항-cd22 항체 컨주게이트
CA2887895C (en) 2012-10-12 2019-10-29 Adc Therapeutics Sarl Pyrrolobenzodiazepine-anti-cd19 antibody conjugates
PT2906296T (pt) 2012-10-12 2018-06-01 Medimmune Ltd Conjugados de pirrolobenzodiazepina-anticorpo
CA2885315C (en) 2012-10-12 2020-06-23 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
ES2680153T3 (es) 2012-10-12 2018-09-04 Adc Therapeutics Sa Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas
RS53818B1 (en) 2012-10-12 2015-06-30 Spirogen Sàrl PIROLOBENZODIAZEPINI I NJIHOVI conjugated
WO2014057120A1 (en) 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Pyrrolobenzodiazepine-antibody conjugates
CN110452242A (zh) 2012-12-21 2019-11-15 麦迪穆有限责任公司 吡咯并苯并二氮杂卓及其结合物
CN105246894A (zh) 2012-12-21 2016-01-13 斯皮罗根有限公司 用于治疗增殖性和自身免疫疾病的非对称吡咯并苯并二氮杂卓二聚物
EP4306649A3 (de) * 2013-02-22 2024-04-03 Promega Corporation Stabilisierte formulierung zum lumineszenznachweis von luciferase und nukleosidphosphaten
JP6669500B2 (ja) 2013-02-25 2020-03-18 ジェネンテック， インコーポレイテッド 薬物耐性ａｋｔ変異体を検出し治療するための方法及び組成物
JP6340019B2 (ja) 2013-03-13 2018-06-06 メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ ピロロベンゾジアゼピン及びそのコンジュゲート
KR102057755B1 (ko) 2013-03-13 2019-12-19 메디뮨 리미티드 피롤로벤조디아제핀 및 그의 컨쥬게이트
CA2905181C (en) 2013-03-13 2020-06-02 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof for providing targeted therapy
KR20150127199A (ko) 2013-03-14 2015-11-16 제넨테크, 인크. 항-b7-h4 항체 및 면역접합체
AR095443A1 (es) 2013-03-15 2015-10-14 Fundación Centro Nac De Investig Oncológicas Carlos Iii Heterociclos condensados con acción sobre atr
BR112015020290A2 (pt) 2013-03-15 2017-10-10 Genentech Inc métodos para tratar um câncer, para prevenir câncer, para inibir proliferação, para tratar terapeuticamente um mamífero, para tratar uma disfunção, para reduzir níveis de proteína spp1, para tratar terapeuticamente um câncer, para tratar um indivíduo e para inibir proliferação celular, artigo, anticorpos e usos
CA2912359A1 (en) 2013-07-03 2015-01-08 F. Hoffmann-La Roche Ag Heteroaryl pyridone and aza-pyridone amide compounds
KR20160042080A (ko) 2013-08-12 2016-04-18 제넨테크, 인크. 1-(클로로메틸)-2,3-디히드로-1H-벤조[e]인돌 이량체 항체-약물 접합체 화합물, 및 사용 및 치료 방법
EP3046940B1 (de) 2013-09-17 2019-07-03 F.Hoffmann-La Roche Ag Verfahren zur verwendung von anti-lgr5-antikörpern
EP3054983B1 (de) 2013-10-11 2019-03-20 Medimmune Limited Pyrrolobenzodiazepin-antikörper-konjugate
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
US9956299B2 (en) 2013-10-11 2018-05-01 Medimmune Limited Pyrrolobenzodiazepine—antibody conjugates
US9950078B2 (en) 2013-10-11 2018-04-24 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
WO2015083059A1 (en) 2013-12-02 2015-06-11 Novartis Ag Forms of the egfr inhibitor
KR101813830B1 (ko) 2013-12-05 2017-12-29 에프. 호프만-라 로슈 아게 친전자성 작용기를 갖는 헤테로아릴 피리돈 및 아자-피리돈 화합물
AU2014362238A1 (en) 2013-12-13 2016-06-09 Genentech, Inc. Anti-CD33 antibodies and immunoconjugates
WO2015095212A1 (en) 2013-12-16 2015-06-25 Genentech, Inc. 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
AU2015209154A1 (en) 2014-01-24 2017-02-16 Genentech, Inc. Methods of using anti-STEAP1 antibodies and immunoconjugates
JP6588917B2 (ja) 2014-01-29 2019-10-09 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 生細胞への適用のためのプロ基質
WO2015116867A1 (en) 2014-01-29 2015-08-06 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
WO2015136016A2 (en) 2014-03-13 2015-09-17 F. Hoffmann-La Roche Ag Therapeutic combinations with estrogen receptor modulators
GB201406767D0 (en) 2014-04-15 2014-05-28 Cancer Rec Tech Ltd Humanized anti-Tn-MUC1 antibodies anf their conjugates
CA2946662A1 (en) 2014-05-22 2015-11-26 Genentech, Inc. Anti-gpc3 antibodies and immunoconjugates
CN106459202A (zh) 2014-06-11 2017-02-22 豪夫迈·罗氏有限公司 抗LgR5抗体及其用途
WO2016037644A1 (en) 2014-09-10 2016-03-17 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
WO2016040788A1 (en) 2014-09-11 2016-03-17 Promega Corporation Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
MA40579A (fr) 2014-09-12 2016-03-17 Genentech Inc Anticorps anti-cll-1 et immunoconjugués
KR20170052600A (ko) 2014-09-12 2017-05-12 제넨테크, 인크. 시스테인 가공된 항체 및 콘주게이트
EP3191134B1 (de) 2014-09-12 2019-11-20 Genentech, Inc. Anthracyclindisulfidzwischenprodukte, antikörper-wirkstoff-konjugate und verfahren
DK3191135T3 (da) 2014-09-12 2020-10-12 Genentech Inc Anti-HER2-antistoffer og immunokonjugater
CA2959689A1 (en) 2014-09-17 2016-03-24 Genentech, Inc. Pyrrolobenzodiazepines and antibody disulfide conjugates thereof
JP6730261B2 (ja) 2014-09-17 2020-07-29 ジェネンテック， インコーポレイテッド 抗ｈｅｒ２抗体を含む免疫複合体
CN111303159A (zh) 2014-10-02 2020-06-19 豪夫迈·罗氏有限公司 用于治疗由布鲁顿酪氨酸激酶(btk)介导的疾病的吡唑甲酰胺化合物
JP6510041B2 (ja) 2014-10-08 2019-05-08 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 生物発光サクシネート検出アッセイ
EP3223854A1 (de) 2014-11-25 2017-10-04 ADC Therapeutics SA Pyrrolobenzodiazepin-antikörper-konjugate
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201506389D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
WO2016205176A1 (en) 2015-06-15 2016-12-22 Genentech, Inc. Antibodies and immunoconjugates
US10501545B2 (en) 2015-06-16 2019-12-10 Genentech, Inc. Anti-CLL-1 antibodies and methods of use
DK3341376T3 (da) 2015-08-26 2021-03-29 Fundacion Del Sector Publico Estatal Centro Nac De Investigaciones Oncologicas Carlos Iii F S P Cnio Kondenserede tricykliske forbindelser som proteinkinase-inhibitorer
MA43345A (fr) 2015-10-02 2018-08-08 Hoffmann La Roche Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
MA43354A (fr) 2015-10-16 2018-08-22 Genentech Inc Conjugués médicamenteux à pont disulfure encombré
MA45326A (fr) 2015-10-20 2018-08-29 Genentech Inc Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
US10639378B2 (en) 2016-06-06 2020-05-05 Genentech, Inc. Silvestrol antibody-drug conjugates and methods of use
JP6493316B2 (ja) * 2016-06-21 2019-04-03 東亜ディーケーケー株式会社 変異型甲虫ルシフェラーゼ、遺伝子、組換えベクター、形質転換体、及び変異型甲虫ルシフェラーゼの製造方法
CN109689111B (zh) 2016-08-11 2024-04-05 基因泰克公司 吡咯并苯并二氮杂䓬前药及其抗体缀合物
CA3039406A1 (en) * 2016-09-19 2018-03-22 University Of Southern California Non-radioactive cytotoxicity assays
EP3526343A4 (de) * 2016-10-13 2020-08-05 Promega Corporation Thermisch stabile luciferase mit verbessertem widerstand gegen die hemmung durch luciferinzerfallsprodukte
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
US11697680B2 (en) 2016-11-21 2023-07-11 Cureab Gmbh Anti-GP73 antibodies and immunoconjugates
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
US11160872B2 (en) 2017-02-08 2021-11-02 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
DK3579883T3 (da) 2017-02-08 2021-09-06 Adc Therapeutics Sa Pyrrolobenzodiazepin-antistofkonjugater
CN110582505B (zh) 2017-04-18 2021-04-02 免疫医疗有限公司 吡咯并苯并二氮杂*缀合物
CN110536703A (zh) 2017-04-20 2019-12-03 Adc治疗有限公司 使用抗axl抗体-药物缀合物的组合疗法
US11318211B2 (en) 2017-06-14 2022-05-03 Adc Therapeutics Sa Dosage regimes for the administration of an anti-CD19 ADC
JP7350713B2 (ja) 2017-08-04 2023-09-26 プロメガ コーポレイション ベンゾチアゾールルシフェリンアナログを安定化させるための組成物及び方法
SI3668874T1 (sl) 2017-08-18 2022-04-29 Medimmune Limited Pirolobenzodiazepinski konjugati
RU2020113749A (ru) 2017-09-20 2021-10-20 пиЭйч ФАРМА Ко., ЛТД. Аналоги таиланстатина
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
JP2021526800A (ja) * 2018-06-05 2021-10-11 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 熱安定性ルシフェリンと共に生物発光アッセイに使用するためのルシフェラーゼ酵素
GB201908128D0 (en) 2019-06-07 2019-07-24 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
WO2021131021A1 (ja) 2019-12-27 2021-07-01 中外製薬株式会社 抗ｃｔｌａ－４抗体およびその使用
CA3177562A1 (en) 2020-05-03 2021-11-11 Tong Zhu Antibody-drug conjugates (adcs) comprising an anti-trop-2 antibody, compositions comprising such adcs, as well as methods of making and using the same
WO2021231400A1 (en) 2020-05-12 2021-11-18 Accutar Biotechnology, Inc. Bis-aryl ethers containing n-acyl azetidine as egfr/her2 inhibitors
MX2023008000A (es) 2021-01-04 2023-07-13 Mersana Therapeutics Inc Conjugados de anticuerpo dirigido a b7-h4 y farmaco, y metodos de uso de los mismos.
EP4301418A1 (de) 2021-03-03 2024-01-10 Sorrento Therapeutics, Inc. Antikörper-wirkstoff-konjugate mit einem anti-bcma-antikörper
WO2022233782A1 (en) 2021-05-03 2022-11-10 Lead Discovery Center Gmbh Composition comprising an inhibitor of mitochondrial transcription
KR20240024255A (ko) 2021-06-25 2024-02-23 추가이 세이야쿠 가부시키가이샤 항ctla-4 항체의 사용
CR20240026A (es) 2021-06-25 2024-03-14 Chugai Seiyaku Kk Anticuerpo anti-ctla-4
WO2023173026A1 (en) 2022-03-10 2023-09-14 Sorrento Therapeutics, Inc. Antibody-drug conjugates and uses thereof
TW202406934A (zh) 2022-05-03 2024-02-16 美商建南德克公司 抗Ｌｙ６Ｅ抗體、免疫結合物及其用途

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US518155A (en) * 1894-04-10 martin
SE428379B (sv) * 1978-05-31 1983-06-27 Lkb Produkter Ab Bioluminiscens bestemning av atp och reagens herfor
US4412001A (en) * 1981-01-30 1983-10-25 Board Of Trustees Of The University Of Illinois Isolation of bacterial luciferase
US4503142A (en) * 1982-06-25 1985-03-05 Litton Bionetics, Inc. Open reading frame vectors
US4581335A (en) * 1982-12-01 1986-04-08 Texas A&M University System Process for producing a cloned luciferase-synthesizing microorganism
US5096825A (en) * 1983-01-12 1992-03-17 Chiron Corporation Gene for human epidermal growth factor and synthesis and expression thereof
US5380831A (en) * 1986-04-04 1995-01-10 Mycogen Plant Science, Inc. Synthetic insecticidal crystal protein gene
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US5583024A (en) * 1985-12-02 1996-12-10 The Regents Of The University Of California Recombinant expression of Coleoptera luciferase
US5221623A (en) * 1986-07-22 1993-06-22 Boyce Thompson Institute For Plant Research, Inc. Use of bacterial luciferase structural genes for cloning and monitoring gene expression in microorganisms and for tagging and identification of genetically engineered organisms
US4968613A (en) * 1987-07-29 1990-11-06 Kikkoman Corporation Luciferase gene and novel recombinant DNA as well as a method of producing luciferase
US5182202A (en) 1987-11-30 1993-01-26 Kikkoman Corporation Purified luciferase from luciola cruciata
JPH088864B2 (ja) 1988-04-12 1996-01-31 キッコーマン株式会社 ルシフェラーゼ
US5604123A (en) * 1988-08-09 1997-02-18 Toray Industries, Inc. Luciferase, gene encoding the same and production process of the same
US5049358A (en) * 1988-09-30 1991-09-17 Miles Inc. Composition and test device for assaying for proteins
US5196524A (en) * 1989-01-06 1993-03-23 Eli Lilly And Company Fusion reporter gene for bacterial luciferase
DE69026851T2 (de) * 1989-02-14 1996-10-31 Wako Pure Chem Ind Ltd Verfahren zur Erhöhung von Chemilumineszenz
US5292658A (en) 1989-12-29 1994-03-08 University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center Cloning and expressions of Renilla luciferase
US5219737A (en) 1990-03-27 1993-06-15 Kikkoman Corporation Mutant luciferase of a firefly, mutant luciferase genes, recombinant dnas containing the genes and a method of producing mutant luciferase
US5283179A (en) * 1990-09-10 1994-02-01 Promega Corporation Luciferase assay method
US5480789A (en) * 1991-04-01 1996-01-02 Florigene Europe B.V. Genetically transformed rose plants and methods for their production
JP3048466B2 (ja) * 1991-06-27 2000-06-05 キッコーマン株式会社 耐熱性ホタルルシフェラーゼ、耐熱性ホタルルシフェラーゼ遺伝子、新規な組み換え体ｄｎａ、及び耐熱性ホタルルシフェラーゼの製造法
US5229285A (en) * 1991-06-27 1993-07-20 Kikkoman Corporation Thermostable luciferase of firefly, thermostable luciferase gene of firefly, novel recombinant dna, and process for the preparation of thermostable luciferase of firefly
US5168202A (en) * 1991-08-30 1992-12-01 Platt Saco Lowell Corporation Microprocessor control of electric motors
AU657584B2 (en) * 1991-10-30 1995-03-16 Plant Genetic Systems N.V. Modified genes and their expression in plant cells
US5629168A (en) * 1992-02-10 1997-05-13 British Technology Group Limited Chemiluminescent enhancers
GB9301118D0 (en) 1993-01-21 1993-03-10 Secr Defence Enzyme linked assays
AT401526B (de) * 1993-02-10 1996-09-25 Scheirer Winfried Reagenzlösung zur stabilisierung der lumineszenz bei der luciferasemessung
CA2104815A1 (en) * 1993-02-26 1994-08-27 Naotaka Kuroda Method for measuring adenyl group-containing substances
EP0689587B1 (de) 1994-01-03 2008-04-09 Promega Corporation Mutierte luziferasen
US6387675B1 (en) * 1994-01-03 2002-05-14 Promega Corporation Mutant luciferases
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
GB2301592B (en) 1994-03-23 1998-06-17 Secr Defence Luciferases
GB9501170D0 (en) * 1994-03-23 1995-03-08 Secr Defence Luciferases
DE69430327T2 (de) 1994-07-13 2002-10-31 Secr Defence Brit Mikrobiologisches testverfahren und reagenzien
US5786464C1 (en) * 1994-09-19 2012-04-24 Gen Hospital Corp Overexpression of mammalian and viral proteins
US5795737A (en) * 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US5670356A (en) 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
JP4342608B2 (ja) 1995-01-20 2009-10-14 スリーエム イノベイティブ プロパティーズ カンパニー 突然変異体ルシフェラーゼ
US5744320A (en) * 1995-06-07 1998-04-28 Promega Corporation Quenching reagents and assays for enzyme-mediated luminescence
US5716851A (en) * 1996-01-16 1998-02-10 Bayer Corporation Glass/cellulose as protein reagent
US6020192A (en) * 1996-01-18 2000-02-01 University Of Florida Humanized green fluorescent protein genes and methods
US5874304A (en) * 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
JPH09294600A (ja) 1996-04-26 1997-11-18 Kikkoman Corp 複数のプロモーター活性の測定法
US6114148C1 (en) * 1996-09-20 2012-05-01 Gen Hospital Corp High level expression of proteins
WO1998013487A1 (en) * 1996-09-27 1998-04-02 Maxygen, Inc. Methods for optimization of gene therapy by recursive sequence shuffling and selection
US5976796A (en) * 1996-10-04 1999-11-02 Loma Linda University Construction and expression of renilla luciferase and green fluorescent protein fusion genes
GB9707486D0 (en) 1997-04-11 1997-05-28 Secr Defence Enzyme assays
US6074859A (en) * 1997-07-08 2000-06-13 Kikkoman Corporation Mutant-type bioluminescent protein, and process for producing the mutant-type bioluminescent protein
AU8148398A (en) * 1997-07-15 1999-02-10 Dow Agrosciences Llc Nucleotide sequences of genes encoding sink proteins and uses thereof for improving the nutritional quality of feeds
US6602677B1 (en) 1997-09-19 2003-08-05 Promega Corporation Thermostable luciferases and methods of production
EP1015601B1 (de) 1997-09-19 2015-01-07 Promega Corporation Thermostabile luciferasen und verfahren zu deren herstellung
US6130313A (en) * 1997-10-02 2000-10-10 Clontech Laboratories, Inc. Rapidly degrading GFP-fusion proteins
US6306600B1 (en) * 1998-04-17 2001-10-23 Clontech Laboratories, Inc. Rapidly degrading GFP-fusion proteins and methods of use
GB9823468D0 (en) 1998-10-28 1998-12-23 Secr Defence Novel enzyme
GB9925161D0 (en) 1999-10-26 1999-12-22 Secr Defence Novel enzyme
AU772485C (en) 1999-10-26 2004-11-18 Promega Corporation Novel enzyme
US7879540B1 (en) * 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
US20030157643A1 (en) * 2000-08-24 2003-08-21 Almond Brian D Synthetic nucleic acids from aquatic species
US7083911B2 (en) * 2001-02-16 2006-08-01 Promega Corporation Method for detection of ATP
WO2005035719A2 (en) * 2003-10-03 2005-04-21 Board Of Control Of Michigan Technological University Modified luciferase
JP5244942B2 (ja) 2011-04-25 2013-07-24 株式会社グレイプ 筋交い取付構造

Also Published As

Publication number Publication date
US20090311769A1 (en) 2009-12-17
WO2001020002A1 (en) 2001-03-22
JP2003509051A (ja) 2003-03-11
US7241584B2 (en) 2007-07-10
EP1630231A3 (de) 2006-05-31
ES2253929T3 (es) 2006-06-01
EP1630231A2 (de) 2006-03-01
JP4520084B2 (ja) 2010-08-04
AU2215600A (en) 2001-04-17
US20120009647A1 (en) 2012-01-12
US6602677B1 (en) 2003-08-05
US8822170B2 (en) 2014-09-02
AU785294B2 (en) 2007-01-04
ATE311461T1 (de) 2005-12-15
US20030232404A1 (en) 2003-12-18
EP1131441A1 (de) 2001-09-12
EP1131441B1 (de) 2005-11-30
CA2350823A1 (en) 2001-03-22
US8030017B2 (en) 2011-10-04
US20060183212A1 (en) 2006-08-17
DE69928687T2 (de) 2006-08-24
US20090137019A1 (en) 2009-05-28

Similar Documents

Publication Publication Date Title
DE69928687D1 (en) Thermostabile luciferase aus photuris pennsylvanica und pyrophorus plagiophthalamus und hertsellungsmethoden
WO1999014336A3 (en) Thermostable luciferases and methods of production
ATE391769T1 (de) Mutierte luziferasen
GB9501170D0 (en) Luciferases
EP0489319A3 (en) Composite foam with low thermoconductivity
WO2001031028A3 (en) Mutant luciferase
WO1994005732A3 (en) Carbon blacks
DE69914807D1 (de) Thermisch leitfähiger verbundwerkstoff
DK1479763T3 (da) Mutant luciferase med foröget termistabilitet
HK1084151A1 (en) Interleukin-18 mutants, their production and use
DE69432753D1 (de) Kompatibilisierter russ, herstellungsverfahren und methode zum gebrauch
TW324020B (en) Process of producing a rubber product with low air permeability
ES2191059T3 (es) Procedimiento para fabricar pelets de fibra de carbono, y pelets resultantes del mismo.
EP2284271A3 (de) Mutierte Luziferase
ES448793A1 (es) Procedimiento para la produccion de cerillas de friccion.
Murray Jr The voice of the composer: Theory and practice in the works of Pietro Pontio.(Volumes I and II)
WO2000055111A3 (en) Bis(1,3-dihydroxy-prop-2-yl)amine and derivatives thereof in the manufacture of polymers
FR2755505B1 (fr) Extracteur d'air destine a la ventilation
SIMPSON EDWARD AXEL ROFFMAN: FURNITURE FOR A TRANSITIONAL AGE
Borish " The lass of the farm": Health, domestic roles, and the culture of farm women in Hartford County, Connecticut, 1820-1870
Preece Housework and American standards of living, 1920-1980
ZA200006695B (en) Granulator organosilane preparation, process for the production thereof and use thereof.
Miller Mamoth mystery
MCELROY Firefly luciferase-structure and function(Final Report, 1 Jun. 1986- 31 May 1988)
Galashkina Dependence of the dispersion of the refractive index of potassium metaphosphate glass on its content of D sub 2 O and H sub 2 O

Legal Events

Date Code Title Description
8364 No opposition during term of opposition